News from invitae corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 23, 2020, 07:30 ET Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2020 financial results on ...


Oct 08, 2020, 07:30 ET New Study Finds Germline Genetic Testing Detects Actionable Findings Missed by Tumor-only Sequencing

Tumor-only genetic sequencing misses medically actionable genetic variants in cancer patients that germline genetic tests identify, according to a...


Oct 05, 2020, 07:30 ET Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that on October 2, 2020, it completed the transaction to bring...


Sep 11, 2020, 07:30 ET Invitae Appoints Kimber Lockhart to its Board of Directors

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Kimber Lockhart to its Board of Directors,...


Sep 03, 2020, 07:30 ET Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a nationwide study to better understand the role...


Sep 01, 2020, 07:30 ET Invitae to Participate in the Morgan Stanley Virtual Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will virtually participate...


Aug 04, 2020, 18:37 ET Invitae Reports Inducement Grants Under NYSE Rule 303A.08

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it granted restricted stock units ("RSUs") to Kenneth D....


Aug 04, 2020, 16:05 ET Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended...


Jul 21, 2020, 07:05 ET Invitae to Announce Second Quarter 2020 Financial Results on August 4, 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2020 financial results...


Jun 22, 2020, 07:00 ET Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

Invitae (NYSE: NVTA), a leading genetics company, and ArcherDX, a leading genomics analysis company democratizing precision oncology, today announced ...


Jun 11, 2020, 07:30 ET Recent Research And New Multidisciplinary Framework For Genetic Testing In Prostate Cancer Supports Broader Use Of Panels, Testing In Early Stage Disease

New recommendations from a large, multidisciplinary consensus conference published this week in the Journal of Clinical Oncology suggest expanding...


May 28, 2020, 07:30 ET Invitae to Present at the William Blair 40th Annual Growth Stock Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will virtually present at...


May 07, 2020, 07:30 ET Invitae makes it easier for consumers to access medical genetic tests in Canada

Invitae (NYSE: NVTA), a leader in medical genetics, today announced the expansion of online ordering for its high-quality medical genetic tests to...


May 05, 2020, 16:05 ET Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the first quarter ended...


Apr 21, 2020, 16:05 ET Invitae to announce first quarter 2020 financial results on May 5, 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2020 financial results on ...


Apr 07, 2020, 07:30 ET Invitae launches enhanced capabilities to support telemedicine

Invitae (NYSE: NVTA), a leading medical genetics company today announced new tools to help obstetrician/gynecologists, oncologists, genetic...


Apr 06, 2020, 16:05 ET Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Underwritten Public Offering

Invitae Corporation (NYSE: NVTA) today announced the closing of its underwritten public offering of 20,444,444 shares of its common stock, including...


Apr 01, 2020, 22:48 ET Invitae Announces Pricing of Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 17,777,778 shares of its common stock at a price...


Apr 01, 2020, 16:17 ET Invitae Announces Proposed Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common...


Mar 23, 2020, 07:30 ET Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the U.S. and Canada

Invitae (NYSE: NVTA), a leading medical genetics company today announced its partnership with the Muscular Dystrophy Association (MDA) to offer...


Mar 10, 2020, 16:22 ET Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into definitive agreements to acquire YouScript, ...


Mar 10, 2020, 16:22 ET Invitae Acquires Diploid, Maker of Artificial-Intelligence Engine to Enable Clinical Diagnosis Using Whole Genome Sequencing in Minutes

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced today the acquisition of Diploid, a privately held Belgian company...


Mar 03, 2020, 07:30 ET Invitae to Present at Oppenheimer's 30th Annual Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co founder and chief executive officer of...


Feb 25, 2020, 07:27 ET Invitae to Present at the Cowen and Company's 40th Annual Health Care Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of...


Feb 20, 2020, 07:30 ET Invitae to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of...